Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Medical Industry Feature

The Importance of Diagnosing Dry Eye Disease Early

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Here’s a quick review of why a timely diagnosis of dry eye disease is so important and how a treatment option may help address the signs and symptoms.

  • Sponsored by

  • Overview

    The earlier you diagnose and treat dry eye disease with a prescription therapy, the better the outcomes. Learn more with Dr. Margeurite McDonald in this brief video. Dr. McDonald is a Clinical Professor of Ophthalmology at New York University in Manhattan and at the Tulane University Medical School in New Orleans.

    ©2024 Bausch + Lomb. XDR.0252.USA.24

  • Indication

    Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

  • Important Safety Information

    • Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
    • In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
    • To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
    • Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
    • Safety and efficacy in pediatric patients below the age of 17 years have not been established.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

    Click here for full Prescribing Information.

Schedule14 Oct 2024